Fig. 4From: Lapatinib in combination with capecitabine versus continued use of trastuzumab in breast cancer patients with trastuzumab-resistance: a retrospective study of a Chinese populationMultivariate analysis for progression-free survival Derived from the Cox regression model. HR hormone receptors status; *Reference groupBack to article page